Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
i-PRF for Stage 3 Grade B Periodontitis
NCT07029035Completed
- Sponsor
- Sağlık Bilimleri Üniversitesi
- Start
- Dec 2023
- Primary completion
- Dec 2024
- Modality
- Device-based Delivery
- Countries
- 1
01
Overview
Randomised, single-blind trial of platelet rich fibrin in periodontitis (2 arms), sponsored by Sağlık Bilimleri Üniversitesi. Primary endpoints: Transforming Growth Factor Beta levels in Gingival Crevicular Fluid at 3 months, Platelet-Derived Growth Factor levels in Gingival Crevicular Fluid at 3 months and 2 more. Started Dec 2023; status: completed.
02
Drugs
platelet rich fibrin
03
Conditions
periodontitis
Beyond the preview
Go deeper on NCT07029035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07029035.